Tumor-induced aberrant angiogenesis, primarily driven by pro-angiogenic factors like VEGF, creates a hypoxic microenvironment that suppresses anti-tumor immune responses and facilitates pro-tumor inflammatory cell infiltration, thereby limiting the efficacy of IC inhibitors (89). Here, VEGFA is linked to neoplasm.